ArsenalBio Secures $325M with Regeneron, BMS Backing
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
- Latest
- Trending
ArsenalBio raises $325M to advance solid tumor CAR-T therapies. Focus on kidney, prostate cancer with innovative genomic technology.
Meta's Llama 3 AI assistant is expanding globally with new features, including the ability to animate visuals. Although it may ...
Discover how easy and essential it is to back up your Mac with Time Machine. Learn how to use it, ...
Razer's Kishi Ultra is compatible with tablets, offering Sensa haptics, but not for iOS. The Razer Nexus app is required ...
Samsung is expected to launch the Samsung Galaxy Z Fold 6 in July 2024 with a possible upgrade to a ...
The Nothing Ear (a) earbuds offer improved sound with 11mm drivers, vibrant color options, and support for hi-res audio and ...
Looking for a free live stream of Man City vs Arsenal or other sports events? Find out if there are ...
Madison native Brandi Grayson, who grew up in foster care, aims to provide a safe space for underprivileged youth through ...
Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
America needs a "dead hand" system more than ever. Algorithms play a critical role in learning, but their designers determine ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.